Skip to content
Biodatica
Start free

Investigator

Martin Graham

EDI THERAPEUTICS LLC · funded by NIDA, NHLBI

Companies
2

Resolved onto their grants.

Grants
2

Federal awards on file.

Non-dilutive funding
$589k

Summed across those awards.

First award
Sep 15, 2025

Latest Jun 1, 2026.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R41

    Chimectin as a novel wound biologic for xylazine-induced tissue injury

    $274k

    Jun 1, 2026NIDAEDI THERAPEUTICS LLCNIH RePORTER · 11239737 (opens the source filing in a new tab)

  2. R41

    Full Gene Replacement for Hemophilia A Enabled by the StitchR Technology

    $314k

    Sep 15, 2025NHLBIEMPRIME THERAPEUTICS INCNIH RePORTER · 11184831 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources